Port-Site Metastasis in Gynecological Malignancies
Kelly Benabou(Bridgeport Hospital), Gulden Menderes(Yale University), Masoud Azodi(Yale University), Wafa Khadraoui(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Pei Hui(First Affiliated Hospital of Zhengzhou University), Tarek Khader(Yale University), Rodrigo Fernández(Bridgeport Hospital)
JSLS Journal of the Society of Laparoscopic & Robotic Surgeons
January 1, 2021
Cited by 11
Related Papers
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
|PLoS Biology|2021|233
Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice
|Modern Pathology|2013|174
Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis
|The American Journal of Surgical Pathology|2008|92
Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer
|JAMA Network Open|2023|41